Dihydroergotamine is a vasoconstrictor and serotonin receptor agonist that acts on 5-HT1B/1D receptors, which helps reduce neurogenic inflammation and cerebral blood vessel dilation associated with cluster headaches. By modulating neurotransmitter activity and vascular tone, it effectively interrupts the pathophysiological cascade of cluster headache pain and provides rapid symptomatic relief.